Equity and dividends

As per December 11th August 2016, the company reported equity is NOK 52 334 799 consisting of 17 444 933 shares with a nominal value of NOK 3,- per share.

The Board of Directors continuously assesses the working capital and investment capital needed to meet future growth, especially within the field of pharma, and has considered this to be more important than paying dividends. However, a policy of not paying dividends has not been adopted by the Board.

No dividends have been paid to the Company’s shareholders for the period 2004 - 2014.

Contact Us

For more information, please visit our profile on the Oslo Stock Exchange website or contact:

Kjetil Ramsøy
Tel: (+47) 906 12 943

NattoPharma contact information:
Main Office: Kirkeveien 59B NO-1363 Høvik,Norway
North American Subsidary: 328 Amboy Ave.,Ste. D,Metuchen, NJ 08840
Tel: (+1) 609-454-2992
Created by:
Nutricon logo.
Search term: